| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -100.00K | $ -120.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -2.61M | $ -2.06M | $ -2.80M | $ -2.83M | $ -2.40M |
| EBITDA | $ -2.51M | $ -1.86M | $ -3.52M | $ -5.74M | $ -3.24M |
| Net Income | $ -4.67M | $ -3.02M | $ -4.40M | $ -6.63M | $ -4.20M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.18M | $ 98.00K | $ 177.00K | $ 812.00K | $ 2.38M |
| Total Assets | $ 20.78M | $ 6.37M | $ 8.25M | $ 8.74M | $ 9.43M |
| Total Debt | $ 18.55M | $ 18.14M | $ 16.69M | $ 14.25M | $ 11.79M |
| Net Debt | $ 17.37M | $ 18.04M | $ 16.51M | $ 13.53M | $ 11.24M |
| Total Liabilities | $ 45.68M | $ 42.88M | $ 42.32M | $ 38.38M | $ 32.76M |
| Stockholders' Equity | $ -24.91M | $ -36.52M | $ -34.07M | $ -29.63M | $ -23.32M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.04M | $ -3.62M | $ -2.60M | $ -3.22M | $ -2.12M |
| Operating Cash Flow | $ -3.04M | $ -3.62M | $ -2.60M | $ -2.97M | $ -1.98M |
| Investing Cash Flow | $ -13.51M | $ 0.00 | $ 95.00K | $ 1.39M | $ -1.31M |
| Financing Cash Flow | $ 17.63M | $ 1.99M | $ 2.03M | $ 3.33M | $ -1.38M |
Jyong Biotech Ltd. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.